339 related articles for article (PubMed ID: 28807161)
21. EZH2 mediates ATO-induced apoptosis in acute myeloid leukemia cell lines through the Wnt signaling pathway.
Zhang H; Gu H; Li L; Ren Y; Zhang L
Tumour Biol; 2016 May; 37(5):5919-23. PubMed ID: 26592252
[TBL] [Abstract][Full Text] [Related]
22. Targeting the bone marrow microenvironment in acute leukemia.
Karantanou C; Godavarthy PS; Krause DS
Leuk Lymphoma; 2018 Nov; 59(11):2535-2545. PubMed ID: 29431560
[TBL] [Abstract][Full Text] [Related]
23. [Recent progress in leukemic stem cell research for childhood leukemia].
Eguchi M; Eguchi-Ishimae M; Ishii E
Rinsho Ketsueki; 2015 Oct; 56(10):1871-81. PubMed ID: 26458424
[TBL] [Abstract][Full Text] [Related]
24. Wnt/β-catenin signaling in bone marrow niche.
Ahmadzadeh A; Norozi F; Shahrabi S; Shahjahani M; Saki N
Cell Tissue Res; 2016 Feb; 363(2):321-35. PubMed ID: 26475718
[TBL] [Abstract][Full Text] [Related]
25. Selective elimination of leukemia stem cells: hitting a moving target.
Crews LA; Jamieson CH
Cancer Lett; 2013 Sep; 338(1):15-22. PubMed ID: 22906415
[TBL] [Abstract][Full Text] [Related]
26. Hypoxia-Activated Prodrug TH-302 Targets Hypoxic Bone Marrow Niches in Preclinical Leukemia Models.
Benito J; Ramirez MS; Millward NZ; Velez J; Harutyunyan KG; Lu H; Shi YX; Matre P; Jacamo R; Ma H; Konoplev S; McQueen T; Volgin A; Protopopova M; Mu H; Lee J; Bhattacharya PK; Marszalek JR; Davis RE; Bankson JA; Cortes JE; Hart CP; Andreeff M; Konopleva M
Clin Cancer Res; 2016 Apr; 22(7):1687-98. PubMed ID: 26603259
[TBL] [Abstract][Full Text] [Related]
27. Understanding of leukemic stem cells and their clinical implications.
Wang X; Huang S; Chen JL
Mol Cancer; 2017 Jan; 16(1):2. PubMed ID: 28137304
[TBL] [Abstract][Full Text] [Related]
28. The genesis and evolution of acute myeloid leukemia stem cells in the microenvironment: From biology to therapeutic targeting.
Chen Y; Li J; Xu L; Găman MA; Zou Z
Cell Death Discov; 2022 Sep; 8(1):397. PubMed ID: 36163119
[TBL] [Abstract][Full Text] [Related]
29. Apoptosis deregulation influences chemoresistance to azaguanine in human leukemic cell lines.
Sarmento-Ribeiro AB; Dourado M; Paiva A; Freitas A; Silva T; Regateiro F; Oliveira CR
Cancer Invest; 2012 Jun; 30(5):331-42. PubMed ID: 22348536
[TBL] [Abstract][Full Text] [Related]
30. Biology and Clinical Relevance of Acute Myeloid Leukemia Stem Cells.
Reinisch A; Chan SM; Thomas D; Majeti R
Semin Hematol; 2015 Jul; 52(3):150-64. PubMed ID: 26111462
[TBL] [Abstract][Full Text] [Related]
31. Reciprocal Interactions of Leukemic Cells with Bone Marrow Stromal Cells Promote Enrichment of Leukemic Stem Cell Compartments in Response to Curcumin and Daunorubicin.
Mohammadi S; Nikbakht M; Sajjadi SM; Rad F; Chahardouli B; Sabour Takanlu J; Rostami Sh; Alimoghaddam K; Ghavamzadeh A; Ghaffari SH
Asian Pac J Cancer Prev; 2017 Mar; 18(3):831-840. PubMed ID: 28441794
[TBL] [Abstract][Full Text] [Related]
32. Can inhibition of the SDF-1/CXCR4 axis eradicate acute leukemia?
Tavor S; Petit I
Semin Cancer Biol; 2010 Jun; 20(3):178-85. PubMed ID: 20637871
[TBL] [Abstract][Full Text] [Related]
33. Targeting bone marrow lymphoid niches in acute lymphoblastic leukemia.
Uy GL; Hsu YM; Schmidt AP; Stock W; Fletcher TR; Trinkaus KM; Westervelt P; DiPersio JF; Link DC
Leuk Res; 2015 Dec; 39(12):1437-42. PubMed ID: 26467815
[TBL] [Abstract][Full Text] [Related]
34. Abnormal bone marrow microenvironment: the "harbor" of acute lymphoblastic leukemia cells.
Chen Z; Zheng Y; Yang Y; Kang J; You MJ; Tian C
Blood Sci; 2021 Apr; 3(2):29-34. PubMed ID: 35402834
[TBL] [Abstract][Full Text] [Related]
35. Bone marrow neoplastic niche in leukemia.
Azizidoost S; Babashah S; Rahim F; Shahjahani M; Saki N
Hematology; 2014 Jun; 19(4):232-8. PubMed ID: 23905984
[TBL] [Abstract][Full Text] [Related]
36. Cell signaling pathways as molecular targets to eliminate AML stem cells.
Rodrigues ACBDC; Costa RGA; Silva SLR; Dias IRSB; Dias RB; Bezerra DP
Crit Rev Oncol Hematol; 2021 Apr; 160():103277. PubMed ID: 33716201
[TBL] [Abstract][Full Text] [Related]
37. Therapeutic targeting of leukemic stem cells in acute myeloid leukemia - the biological background for possible strategies.
Bruserud Ø; Aasebø E; Hernandez-Valladares M; Tsykunova G; Reikvam H
Expert Opin Drug Discov; 2017 Oct; 12(10):1053-1065. PubMed ID: 28748730
[TBL] [Abstract][Full Text] [Related]
38. Leukemia-on-a-chip: Dissecting the chemoresistance mechanisms in B cell acute lymphoblastic leukemia bone marrow niche.
Ma C; Witkowski MT; Harris J; Dolgalev I; Sreeram S; Qian W; Tong J; Chen X; Aifantis I; Chen W
Sci Adv; 2020 Oct; 6(44):. PubMed ID: 33127669
[TBL] [Abstract][Full Text] [Related]
39. Location First: Targeting Acute Myeloid Leukemia Within Its Niche.
Pievani A; Biondi M; Tomasoni C; Biondi A; Serafini M
J Clin Med; 2020 May; 9(5):. PubMed ID: 32443460
[TBL] [Abstract][Full Text] [Related]
40. A review of the chemopreventative and chemotherapeutic properties of the phytochemicals berberine, resveratrol and curcumin, and their influence on cell death via the pathways of apoptosis and autophagy.
D'Arcy MS
Cell Biol Int; 2020 Sep; 44(9):1781-1791. PubMed ID: 32449796
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
